162 related articles for article (PubMed ID: 23972320)
1. Effect of combination of montelukast and levocetirizine on otitis media with effusion: a prospective, placebo-controlled trial.
Ertugay CK; Cingi C; Yaz A; San T; Ulusoy S; Erdogmus N; Ertugay OC
Acta Otolaryngol; 2013 Dec; 133(12):1266-72. PubMed ID: 23972320
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
[TBL] [Abstract][Full Text] [Related]
3. Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine.
Ciebiada M; Barylski M; Gorska Ciebiada M
Am J Rhinol Allergy; 2013; 27(2):e58-62. PubMed ID: 23562192
[TBL] [Abstract][Full Text] [Related]
4. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
Sarkar TK; Sil A; Pal S; Ghosh C; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910
[TBL] [Abstract][Full Text] [Related]
6. Letter in response to "Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial" by Sarkar
Marrouche N; Williams HC
Indian J Dermatol Venereol Leprol; 2018; 84(1):59-60. PubMed ID: 29271368
[No Abstract] [Full Text] [Related]
7. A prospective, randomized, placebo-controlled, double-blind study of montelukast's effect on persistent middle ear effusion.
Schoem SR; Willard A; Combs JT
Ear Nose Throat J; 2010 Sep; 89(9):434-7. PubMed ID: 20859868
[TBL] [Abstract][Full Text] [Related]
8. FDC of montelukast with levocetirizine: focus on bilayer technology.
Rathod RT; Misra D
J Indian Med Assoc; 2009 Aug; 107(8):562-4. PubMed ID: 20112841
[TBL] [Abstract][Full Text] [Related]
9. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial.
Mahatme MS; Dakhale GN; Tadke K; Hiware SK; Dudhgaonkar SD; Wankhede S
Indian J Pharmacol; 2016; 48(6):649-653. PubMed ID: 28066101
[TBL] [Abstract][Full Text] [Related]
11. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
12. Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients.
Patel P; Patel D
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):287-94. PubMed ID: 18814452
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the pharmacokinetics and tolerability of montelukast/levocetirizine administered as a fixed-dose combination and as separate tablets.
Kim S; Ko JW; Kim JR
Int J Clin Pharmacol Ther; 2018 Sep; 56(9):443-450. PubMed ID: 30021691
[TBL] [Abstract][Full Text] [Related]
14. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Soccio AL; Ferrannini A; Vacca A
Br J Dermatol; 2006 Dec; 155(6):1279-82. PubMed ID: 17107402
[TBL] [Abstract][Full Text] [Related]
15. Improvement of otitis media with effusion after treatment of asthma with leukotriene antagonists in children with co-existing disease.
Balatsouras DG; Eliopoulos P; Rallis E; Sterpi P; Korres S; Ferekidis E
Drugs Exp Clin Res; 2005; 31 Suppl():7-10. PubMed ID: 16444906
[TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
17. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
[TBL] [Abstract][Full Text] [Related]
18. The effect of montelukast sodium on the duration of effusion of otitis media.
Combs JT
Clin Pediatr (Phila); 2004; 43(6):529-33. PubMed ID: 15248005
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis.
Amirav I; Luder AS; Kruger N; Borovitch Y; Babai I; Miron D; Zuker M; Tal G; Mandelberg A
Pediatrics; 2008 Dec; 122(6):e1249-55. PubMed ID: 18984650
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial therapy for otitis media with effusion ('secretory' otitis media).
Cantekin EI; McGuire TW; Griffith TL
JAMA; 1991 Dec; 266(23):3309-17. PubMed ID: 1683673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]